The Lancet Journal

Overview
Identity
View All

publication venue for

Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.. 401:967-970. 2023
The legacy of the COVID-19 pandemic for childhood vaccination in the USA.. 401:75-78. 2023
Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.. 400:535-538. 2022
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.. 398:2186-2192. 2021
Uncoupling vaccination from politics: a call to action.. 398:1211-1212. 2021
Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.. 397:1165-1167. 2021
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.. 388:1459-1544. 2016
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.. 380:2197-2223. 2012
Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure.. 354:1164-1168. 1999
Male sexual development in "a sea of oestrogen".. 342:123-124. 1993
Male sexual development in "a sea of oestrogen".. 342:125-125. 1993
Glutamine and the preservation of gut integrity.. 341:1363-1365. 1993
Raised cerebrospinal-fluid copper concentration in Parkinson's disease.. 2:238-241. 1987
Campylobacter pylori detected noninvasively by the 13C-urea breath test.. 1:1174-1177. 1987
CAMPYLOBACTER-PYLORI DETECTED NONINVASIVELY BY THE C-13 UREA BREATH TEST. 1:1174-1177. 1987
Randomised trial of plasma exchange in mild systemic lupus erythematosus.. 1:17-22. 1983
Induction of osteogenesis.. 2:1041-1042. 1981
Lysophospholipases, lipid metabolism, and the pathogenesis of African trypanosomiasis.. 2:1187-1188. 1977
Free fatty acids, complement activation, and polyclonal B-cell stimulation as factors in the immunopathogenesis of African trypanosomiasis.. 2:956-959. 1977
FREE FATTY ACIDS, LYSOPHOSPHOLIPASES, AND THE PATHOGENESIS OF AFRICAN TRYPANOSOMIASIS. 310:91-91. 1977
Free fatty acids, lysophospholipases, and the pathogenesis of African trypanosomiasis.. 2:91-91. 1977
Free fatty acids and pathogenesis of African trypanosomiasis.. 1:750-751. 1977
FREE FATTY-ACIDS AND PATHOGENESIS OF AFRICAN TRYPANOSOMIASIS. 1:750-751. 1977
FREE FATTY-ACIDS, COMPLEMENT ACTIVATION, AND POLYCLONAL B-CELL STIMULATION AS FACTORS IN IMMUNOPATHOGENESIS OF AFRICAN TRYPANOSOMIASIS. 2:956-959. 1977
LYSOPHOSPHOLIPASES, LIPID-METABOLISM, AND PATHOGENESIS OF AFRICAN TRYPANOSOMIASIS. 2:1187-1188. 1977
GASTROINTESTINAL ABSORPTION AND RENAL EXCRETION OF HYDROXYPROLINE PEPTIDES. 280:527-528. 1962
Gastrointestinal absorption and renal excretion of hydroxyproline peptides.. 2:527-528. 1962